Literature DB >> 19710641

Imaging and biomarkers in early Alzheimer's disease and mild cognitive impairment.

R C Petersen1, C R Jack.   

Abstract

A major focus of research on aging and dementia pertains to the prediction of future cognitive decline. Toward this end, several longitudinal studies are under way that are designed to explore early predictors of cognitive impairment. Neuroimaging techniques and biomarkers have shown promise in this application. Ultimately, it is likely that the use of a combination of neuroimaging and chemical biomarkers will be involved in predicting the development of dementia and Alzheimer's disease (AD).

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19710641      PMCID： PMC3098135          DOI： 10.1038/clpt.2009.166

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  28 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Asymmetric cortical degenerative syndromes: clinical and radiologic correlations.

Authors:  R J Caselli; C R Jack; R C Petersen; H W Wahner; T Yanagihara
Journal:  Neurology       Date:  1992-08       Impact factor: 9.910

3.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

4.  Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

Authors:  N C Fox; P A Freeborough
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

5.  Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.

Authors:  N Schuff; D Amend; F Ezekiel; S K Steinman; J Tanabe; D Norman; W Jagust; J H Kramer; J A Mastrianni; G Fein; M W Weiner
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

6.  Vitamin E and donepezil for the treatment of mild cognitive impairment.

Authors:  Ronald C Petersen; Ronald G Thomas; Michael Grundman; David Bennett; Rachelle Doody; Steven Ferris; Douglas Galasko; Shelia Jin; Jeffrey Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal
Journal:  N Engl J Med       Date:  2005-04-13       Impact factor: 91.245

7.  DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment.

Authors:  K Kantarci; R C Petersen; B F Boeve; D S Knopman; S D Weigand; P C O'Brien; M M Shiung; G E Smith; R J Ivnik; E G Tangalos; C R Jack
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

Review 8.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Authors:  E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245
View more
  20 in total

1.  The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes.

Authors:  Laurel A Beckett; Danielle J Harvey; Anthony Gamst; Michael Donohue; John Kornak; Hao Zhang; Julie H Kuo
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 3.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 4.  The rationale for deep brain stimulation in Alzheimer's disease.

Authors:  Zaman Mirzadeh; Ausaf Bari; Andres M Lozano
Journal:  J Neural Transm (Vienna)       Date:  2015-10-06       Impact factor: 3.575

5.  Brain and disease: the long path to discovery and treatment.

Authors:  S L Miksys; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2009-10       Impact factor: 6.875

6.  Longitudinal imaging pattern analysis (SPARE-CD index) detects early structural and functional changes before cognitive decline in healthy older adults.

Authors:  Vanessa H Clark; Susan M Resnick; Jimit Doshi; Lori L Beason-Held; Yun Zhou; Luigi Ferrucci; Dean F Wong; Michael A Kraut; Christos Davatzikos
Journal:  Neurobiol Aging       Date:  2012-02-24       Impact factor: 4.673

7.  Deep brain stimulation: a novel strategy for treating Alzheimer's disease.

Authors:  Constantine G Lyketsos; Steven D Targum; Jo Cara Pendergrass; Andres M Lozano
Journal:  Innov Clin Neurosci       Date:  2012-11

8.  Multi-Kernel Classification for Integration of Clinical and Imaging Data: Application to Prediction of Cognitive Decline in Older Adults.

Authors:  Roman Filipovych; Susan M Resnick; Christos Davatzikos
Journal:  Med Image Comput Comput Assist Interv       Date:  2011

9.  Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.

Authors:  Liyong Wu; Pedro Rosa-Neto; Serge Gauthier
Journal:  Mol Diagn Ther       Date:  2011-12-01       Impact factor: 4.074

Review 10.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.